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Two new families of chiral arenesulfonic acids were synthesised in a short, robust and scalable synthetic
sequence involving a key cross-coupling step of an aromatic scaffold with a suitable chiral auxiliary. The
ﬂexibility of the synthetic route and the ready availability of a range of naturally occurring chiral auxili-
aries allowed us to prepare nine enantiomerically pure sulfonic acids with a tunable stereochemical
environment. Application of the strong chiral Brønsted acids was demonstrated in an enantioselective
nitrone/enol ether 1,3-dipolar cycloaddition.
 2015 Elsevier Ltd. All rights reserved.1. Introduction
Stronger chiral Brønsted acids have recently emerged as power-
ful synthetic tools for important and often novel enantioselective
bond forming reactions.1 Arguably, the most important class is
the BINOL-derived chiral phosphoric acids 1a,b (BPA, Fig. 1) and
related compounds introduced by Akiyama and Terada.2 With
the expansion of the ﬁeld came the need for enhanced acidity,
which has been realised in the form of phosphorodiamidic acid
derivative 1c3 and N-triﬂyl phosphoramides 1d4 and related
derivatives.5 These derivatives can impart high levels of enantio-
control in reactions where the original class of BPAs are either poor
controllers of asymmetry or are catalytically inferior or showed no
catalytic activity.4,5 Therefore, the importance of the contribution
of stronger Brønsted acids to the ﬁeld is apparent, however there
is an upper limit to the acidity of such classes of acids.
Accordingly, future opportunities will arise from other classes
of higher acidity chiral organic acids, such as chiral sulfonic acids,
which could potentially give rise to a broader range of catalytic
applicability. Several enantiomerically pure chiral aliphatic sul-
fonic acids, including long-known camphor sulfonic acid 1i (CSA),
have been prepared for use mostly as resolving reagents.6 The most
recent examples of this class of stronger Brønsted acids are repre-
sented by enantiomerically pure sulfonic acids 1j, which emerged
from a stereoselective addition of sodium bisulﬁte to a suitable
Michael acceptor.7 An even higher Brønsted acidity of chiral sul-
fonic acid was calculated for the simplest member of BINOL-
derived bis-sulfonic acids 1e (BINSA, pKa in DMSO 9.06).5cAlthough BINSA has been known since 1928, its applications in
acid-catalysed transformations remained unexplored until 2008
when it was obtained in enantiomerically pure form.8 Shortly after,
more advanced descendants of BINSA’s 1f8 (R = Ar, Me3Si) and
related disulfonimides 1g,h8 were synthesised.8,9
Recently, Enders and Blanchet reported the syntheses of novel
planar chiral sulfonic acids 1k, 1l and novel axially chiral sulfonic
acids 1m, respectively.10,11 We believed that enhanced reactivity
and enantiocontrol, potentially in a wide range of acid catalysed
reactions, could be harnessed from alternative, novel and readily
accessible classes of chiral sulfonic acids. Herein we report new,
efﬁcient and general routes to a range of novel single enantiomer
arenesulfonic acids and report preliminary enantioselectivity data
in an acid catalysed nitrone/enol ether 1,3-dipolar cycloaddition
reaction.
2. Results and discussion
Our initial design plan was to construct an arenesulfonic acid
bearing two chiral appendages attached to the 2- and 6-positions,
thus creating a chiral environment around the sulfonic acid group
(Scheme 1). Our synthesis plan was therefore to develop straight-
forward, yet synthetically powerful routes through standard cross-
coupling protocols (such as Ulmann, Goldberg, Suzuki, etc.) on
commercial (or readily accessible) arene derivatives to afford novel
stronger Brønsted-acids that could have general applicability in
enantioselective acid catalysed reactions.
We designed two distinctive synthetic routes. In our ﬁrst
approach (Scheme 1, Route A), the plan was to ﬁrst construct a
chiral substituted benzene scaffold 4, and subsequently introduce
the sulfonic acid moiety. This approach would be short in step
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Figure 1. Selected existing stronger Brønsted acids.
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Scheme 1. Retrosynthesis of novel chiral arenesulfonic acids.
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be amenable to library generation. In our second, (Scheme 1, Route
B) we planned to use a sulfonate ester 10 on an appropriate arene
ring as both a directing group for the regioselective introduction of
chiral appendages and a masked acid. Speciﬁcally a Snieckus direc-
ted ortho metalation12 would allow the regiocontrolled synthesis
of an aryl boronic acid 9 which under appropriate conditions
would undergo cross-coupling with a range of chiral coupling part-
ners. Finally a mild hydrolysis of sulfonates 7would ﬁnish the syn-
thesis of 2 in ﬁve steps.
2.1. Route A
In choosing the cross-coupling reaction for the synthesis of the
chiral arene scaffolds, we considered the availability/accessibility
of a small library of chiral appendages/auxiliaries, suitably substi-
tuted arenes, and the robustness/reliability of the coupling reaction
itself. Accordingly, the well-precedented Cu-catalysed Ulmann–
Goldberg coupling of suitable aryl halides with chiral oxazolidi-
nones became our ﬁrst choice.13 Chiral enantiopure oxazolidinones
5a–d were the nitrogen-containing heterocycles of choice since
they are commercially available or easily made in both enan-
tiomeric forms from natural or unnatural aminoacids.14
Using catalytic amounts of copper iodide in the presence of
DMEDA and potassium carbonate, C3 and C2 symmetrical deriva-
tised arenes were readily synthesised in a single operation in good
yields from brominated arenes 6a and 6b using oxazolidinones
5a–d (Scheme 2).
With electron rich C3-symmetrical chiral scaffolds 4a–d and
C2-symmetrical 4e–g in our hands we then investigated the intro-
duction of the sulfonic acid moiety. Using a modiﬁed literatureprocedure for the chlorosulfonation of 1,3,5-trisubstituted ben-
zenes, we isolated directly the desired sulfonic acid and not the
intermediate sulfonyl chloride (Scheme 2).15 Our short route
allowed us to produce signiﬁcant quantities of novel chiral ben-
zenesulfonic acids in a 2 step sequence. The structure of 2b, was
determined from single crystal X-ray diffraction studies and is
reported as the hydroxonium salt in the solid state (Fig. 2).
2.2. Route B
In our ﬁrst route (Route A, above) the sulfonic acid functionality
was introduced in the last step of the synthesis. However, with the
knowledge that arene sulfonate esters are powerful ortho-directing
groups in the Snieckus reaction, in our second route, we decided to
employ these as starting materials.12 Treatment of ethylsulfonate
10 with butyllithium for 6 h at 78 C,16 followed by quenching
of the lithiated intermediate with trimethylborate yielded boronic
acid 11 in excellent yield via this scalable one-pot procedure
(Scheme 3).17
Subsequent Suzuki coupling18 with readily prepared men-
thenyltriﬂate 8a19 provided sulfonate 12 in good yield
(Scheme 3). A second tandem ortho-lithiation/boronate ester
quench provided boronic acid 13, which was a suitable precursor
for further diversiﬁcation. Coupling of 13with readily available tri-
ﬂates 8a, 8b19,20 provided structurally varied sulfonates 7a and 7b
in good yields (Scheme 4). A convenient, high yielding alkaline
hydrolysis of sulfonic esters 7a, 7b followed by acidiﬁcation with
dilute HCl afforded chiral sulfonic acids 2h, 2i.
With a library of two classes of structurally diverse sulfonic
acids 2a–g and 2h, 2i in hand, our next aim was to provide a proof
of principle that they were indeed capable of imparting asymmetry
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Scheme 2. Synthesis of chiral arenesulfonic acids. Reagents and conditions: (i) 1,3,5-tribromobenzene, 6a, CuI, K2CO3, N,N0-dimethylethylenediamine (DMEDA), toluene,
reﬂux 20–30 h; (ii) 1,3-dibromo-5-tert-butylbenzene 6b, CuI, K2CO3, DMEDA, toluene, reﬂux 24 h; (iii) ClSO3H, chloroform, reﬂux, 24–48 h.
Figure 2. Thermal ellipsoids for 2b drawn at 30% probability and selected solvent
omitted for clarity. See Section 4 for details.
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Scheme 3. Synthesis of common precursor for the divergent synthesis of chiral
arenesulfonic acids. Reagents and conditions: (i) (a) n-BuLi, THF, 78 C, 5 h then
(b) B(OMe)3, 78 C? rt, 12 h, 92%; (ii) 8a, Cs2CO3, Pd(PPh3)4, DME, H2O, 70 C, 1 h,
78%.
P. Jakubec et al. / Tetrahedron: Asymmetry 26 (2015) 251–261 253in an acid-catalysed reaction. Inspired by the recent report of
Yamamoto21 we decided to test the new chiral sulfonic acids in
the 1,3-dipolar cycloaddition of nitrone 15 and ethyl vinyl ether
16 (Schemes 5 and 6). Initially, systematic solvent, temperature
and concentration variations were undertaken to determine the
reaction conditions for the optimal catalytic performance of acid
2b in the 1,3-dipolar cycloaddition. This survey revealed that the
best results in terms of enantioselectivity and isolated yield were
obtained when the reaction was performed in chloroform at
35 C at a moderate dilution (Scheme 5, entry 4). With the estab-
lished conditions in hand, sulfonic acids 2a–g were screened
(Scheme 5, entries 3–9). In all cases a high diastereoselectivity
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Scheme 4. Synthesis of chiral arenesulfonic acids 2h, 2i. Reagents and conditions: (i) (a) n-BuLi, THF,78 C, 6.5 h then (b) B(OMe)3,78 C? rt, 1 h, 100% (crude); (ii) ROTf
8, Cs2CO3, Pd(PPh3)4, DME, H2O, 70 C, 2 h; (iii) NaOH, EtOH, 14 h, reﬂux; (iv) HCl, rt, 5 min.
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Scheme 5. Application of catalysts 2a–g in the enantioselective nitrone/enol ether
1,3-dipolar cycloaddition. Reagents and conditions: (i) arenesulfonic acid catalyst,
4 Å MS, CHCl3, 35 C, 24 h, for the yields and stereoselectivities, see the table
below.
Entrya Catalyst endo:exoc Yieldd (%) eee (%)
1 — — 0 —
2 PTSAb 80:20 78 —
3 2a 95:5 83 32
4 2b 93:7 83 30
5 2c 95:5 79 17
6 2d 93:7 83 26
7 2e 94:6 81 19
8 2f 94:6 83 8
9 2g 94:6 81 14
aUnless otherwise stated all reactions were performed on a 0.3 mmol scale, 0.05 M
at 35 C using 10 mol % of catalyst.
bReaction performed at rt for 20 min under the standard reaction conditions.
cDetermined by 1H NMR of the isolated product.
dIsolated yield after column chromatography puriﬁcation.eDetermined by HPLC of
the isolated product, ee and the absolute conﬁguration of the minor diastereomer
was not determined.
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Scheme 6. Application of catalysts 2h, 2i in the enantioselective 1,3-dipolar
cycloaddition. Reagents and conditions: (i) 4 Å MS, CH2Cl2, 40 C, 24 h; using
catalyst 2h (10 mol %): 86%, endo:exo 81:19, 30% ee, using catalyst 2i (10 mol %):
78%, endo:exo 81:19, 19% ee.
254 P. Jakubec et al. / Tetrahedron: Asymmetry 26 (2015) 251–261towards the endo-product was observed and full conversion to the
desired enantiomerically enriched isoxazolidine (R,R)-17 was
achieved after 24 h at 35 C.
Although the obtained enantioselectivities ranged from low to
moderate (ee 8–32%), these results provided a sufﬁcient proof of
principle for the ability of acids 2a–g to induce enantioselectivity
in an acid-catalysed reaction. As expected, a control experimentwithout any catalyst showed no background reaction (Scheme 5,
entry 1).
Due to the signiﬁcant structural differences and different physi-
cal–chemical properties of acids 2a–g and 2h and 2i, an indepen-
dent reaction condition screen was performed for the latter acids.
As a result, slightly modiﬁed reaction conditions were established
for acids 2h and 2i (CH2Cl2, 40 C, Scheme 6). Similar to the pre-
vious results, acids 2h and 2i efﬁciently catalysed the 1,3-dipolar
cycloaddition and gave up to 30% ee of isoxazolidine (S,S)-17
(Scheme 6). It is noteworthy that the opposite (S,S)-enantiomer
of the major endo-diastereomer 17 was formed in the reactions
catalysed by acids 2h, 2i when compared to 2a–g.
3. Conclusion
In conclusion, we have successfully designed and executed
cross-coupling based syntheses of 2 new classes of stronger chiral
Brønsted acids. The catalytic activity and synthetic utility of the
novel chiral sulfonic acids have been demonstrated in a highly
diastereoselective and enantioselective 1,3-dipolar nitrone/enol
ether cycloaddition reaction. Further exploration of the synthetic
utility of these and related sulfonic acids is ongoing in our lab-
oratory and the results will be disclosed in due course.
4. Experimental
For all reactions conducted under anhydrous conditions the
glassware was dried in an oven at 100 C and the reactions were
carried out under a nitrogen atmosphere, unless otherwise stated.
Bulk solutions were evaporated under reduced pressure using a
Büchi rotary evaporator. Reagents used were obtained from com-
mercial suppliers or puriﬁed according to standard procedures.
Petrol ether (PE) refers to distilled light petroleum of fraction
(40–65 C). Flash column chromatography was performed with
commercial solvents using Merck Kieselgel 60 silica gel (200–
400 mesh). Thin layer chromatography (TLC) was performed on
aluminium or glass plates pre-coated with Merck Kieselgel 60
F254 and visualised by ultra-violet radiation or by staining with
either aqueous basic potassium permanganate or vanillin.
Enantiomeric excesses were determined using high performance
liquid chromatography (HPLC) performed on a Hewlett–Packard
Series 1050 series system (column conditions are given with the
compound). Melting points were recorded on a Gallenkamp melt-
ing point apparatus with the sample contained in a thin glass tube
at ambient pressure and are uncorrected.
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RX1 FTIR. Only selected absorbances (mmax in cm1) are reported.
1H, 13C, DEPT, COSY and HMQC NMR spectra were recorded on
Bruker 500 MHz, Bruker 400 MHz and Varian 300 MHz spectrome-
ters. Chemical shifts (dH) are quoted in parts per million
(ppm ± 0.01 ppm) downﬁeld of tetramethylsilane, relative to the
residual protio solvent (dH (CHCl3) = 7.26 ppm) against an internal
deuterium lock. Coupling constants (J) are given in Hertz
(Hz ± 0.1 Hz). The 1H NMR spectra are reported as follows: d/ppm
(multiplicity, number of protons, coupling constants J/Hz, assign-
ment). DEPT and two-dimensional NMR spectroscopy (COSY and
HMQC) were used where appropriate to assist the assignment of
the signals in the 1H NMR and 13C NMR spectra. Low resolution
mass spectrometry (electron impact/chemical ionisation) was
recorded on a Micromass Trio 2000 quadrupole mass spectrometer
and (electrospray) on a Micromass Platform II spectrometer. High
resolution mass spectra (accurate mass) were recorded on a
Thermo Finnigan Mat95XP mass spectrometer. Optical rotations
were recorded using an Optical Activity AA-1000 polarimeter;
speciﬁc rotations ([a]D) are reported in 101 deg cm2 g1; concen-
trations (c) are quoted in g (100 mL)1; D refers to the D-line of
sodium (589 nm); temperatures (T) are given in degrees Celsius
(C). Compounds 5a–d, 6a,b, 10 and 16 are commercially available,
compounds 8a,19 8b20 and 1522 were prepared according to litera-
ture procedures.
4.1. General procedure A for the preparation of C-3 symmetrical
N-aryloxazolidinones 4a–d
1,3,5-Tribromobenzene 6a (1 equiv), potassium carbonate
(4 equiv), copper(I) iodide (1 equiv) and an oxazolidinone 5
(4 equiv) were placed in a dry ﬂask, and 2 sequences vacuum/nitro-
gen were applied. Under nitrogen, dry toluene was added (2 mL per
mmol), and the suspension was stirred vigorously while N,N0-
dimethylethylenediamine was added in one portion (1 equiv). The
resulting dark suspension was reﬂuxed for 18 h (turned blue after
few minutes of heating). It was then cooled to room temperature
and under nitrogen. When the conversion was not complete,
another portion of copper(I) iodide (0.5 equiv), oxazolidinone 5
(1 equiv) as well as N,N0-dimethylethylenediamine (0.5 equiv) was
added, and the suspension reﬂuxed to completion. The mixture
was allowed to cool to room temperature and puriﬁed by chro-
matography on silica gel (the large amount of solid can be ﬁltered
on Celite prior to puriﬁcation, washing with ethyl acetate
thoroughly).
4.1.1. (4S,40S,400S)-3,30,300-Benzene-1,3,5-triyltris(4-propyl-1,3-
oxazolidin-2-one) 4a
Prepared according to general procedure A, on a 5.22 mmol
scale of 1,3,5-tribromobenzene 6a. Reﬂuxed for 30 h (complete
conversion). Puriﬁed by column chromatography on silica gel elut-
ing with petroleum ether/ethyl acetate (1:1) and the recovered
solid was recrystallised from CH2Cl2/PE 2:3 to give 4a (1.12 g,
46%) as a colourless crystalline solid. Mp 83–86 C; IR 1746
(C@O), 1603 (C@C), 1471 (C@C), 1399 (CH3); 1H NMR (CDCl3,
400 MHz) dH 0.96 (t, 9H, J 7.5 Hz, 3  CH3CH2CH2), 1.27–1.47 (m,
6H, 3  CH3CH2CH2), 1.58–1.72 (m, 3H, 3  CH3CH2CHAHB), 1.76–
1.87 (m, 3H, 3  CH3CH2CHAHB), 4.17 (dd, 3H, J 8.0 Hz, 4.0 Hz,
3  NCHCHAHBO), 4.41–4.49 (m, 3H, 3  NCHCHAHBO), 4.49–4.56
(m, 3H, 3  NCHCHAHBO), 7.60 (s, 3H, H-Ar); 13C NMR (CDCl3,
100 MHz) dC 13.8 (CH3CH2CH2), 17.4 (CH3CH2CH2), 33.8
(CH3CH2CH2), 55.9 (NCHCH2O), 66.9 (NCHCH2O), 108.2 (CH-Ar),
138.4 (Cquat-Ar), 155.7 (C@O); m/z (ES+) 482 ([M+Na]+, 45%), 941
([2M+Na]+, 100%), HRMS (ES+) exact mass calculated for [M+Na]+
(C24H33N3O6Na+) requires m/z 482.2262, found m/z 482.2255;
[a]D25 = +142.0 (c 1.0, CHCl3).4.1.2. (4S,40S,400S)-3,30,300-Benzene-1,3,5-triyltris(4-isopropyl-1,3-
oxazolidin-2-one) 4b
Prepared according to general procedure A on a 3 mmol scale of
1,3,5-tribromobenzene 6a. Reﬂuxed for 18 h + 4 h. Puriﬁed on sil-
ica gel eluting with PE/EtOAc 1:1? 2:3 to give 4b (0.860 g, 62%)
as a colourless crystalline solid. Mp 158–161 C; IR 1745 (C@O),
1603 (C@C), 1473 (C@C), 1402/1393 (CH3); 1H NMR (CDCl3,
400 MHz) dH 0.88 (d, 9H, J 7.0 Hz, 3  CH3CHCH3), 0.95 (d, 9H, J
7.0 Hz, 3  CH3CHCH3), 2.22 (td, 3H, J 7.0 Hz, 3.5 Hz,
3  CH3CHCH3), 4.27 (dd, 3H, J 8.0 Hz, 3.5 Hz, 3  NCHCHAHB),
4.39–4.49 (m, 6H, 3  NCHCHAHB), 7.62 (s, 3H, H-Ar); 13C NMR
(CDCl3, 100 MHz) dC 14.5 (CH3CHCH3), 17.8 (CH3CHCH3), 27.7
(CH3CHCH3), 60.2 (NCHCH2), 62.6 (NCHCH2), 109.7 (CH-Ar), 138.4
(Cquat-Ar), 155.7 (C@O); m/z (ES+) 482 ([M+Na]+, 100%), HRMS
(ES+) exact mass calculated for [M+Na]+ (C24H33N3O6Na+) requires
m/z 482.2262, found m/z 482.2262; [a]D25 = +101.4 (c 1.0, CHCl3).
4.1.3. (4S,40S,400S)-3,30,300-Benzene-1,3,5-triyltris(4-isobutyl-1,3-
oxazolidin-2-one) 4c
Prepared according to general procedure A, on a 1.75 mmol
scale of 1,3,5-tribromobenzene 6a. Reﬂuxed for 24 h (complete
conversion). Puriﬁed by chromatography on silica gel eluting with
PE/EtOAc 1:1. The recovered solid was further puriﬁed by recrys-
tallisation from PE/EtOAc 1:1 to give 4c (0.630 g, 72%) as a colour-
less crystalline solid. Mp 170–174 C; IR 1754 (C@O), 1603 (C@C),
1471 (C@C), 1398 (CH3); 1H NMR (CDCl3, 400 MHz) dH 0.96 (d, 9H, J
6.5 Hz, 3  CH3CHCH3), 1.02 (d, 9H, J 6.5 Hz, 3  CH3CHCH3), 1.50–
1.60 (m, 3H, 3  CHCHAHBCH), 1.62–1.74 (m, 3H, 3  CH3CHCH3),
1.79 (ddd, 3H, J 13.0 Hz, 9.0 Hz, 1.5 Hz, 3  CHCHAHBCH), 4.17
(dd, 3H, J 8.0 Hz, 4.0 Hz, 3  NCHCHAHBO), 4.47 (ddd, 3H, J
10.5 Hz, 7.5 Hz, 3.0 Hz, 3  NCHCHAHBO), 4.53 (t, 3H, J 8.0 Hz,
3  NCHCHAHBO), 7.63 (s, 3H, H-Ar); 13C NMR (CDCl3, 100 MHz)
dC 21.7 (CH3CHCH3), 23.6 (CH3CHCH3), 24.8 (CH3CHCH3), 40.7
(CHCH2CH), 54.9 (NCHCH2O), 67.3 (NCHCH2O), 107.3 (CH-Ar),
138.5 (Cquat-Ar), 155.2 (C@O); m/z (ES+) 519 ([M+NH4]+, 95%),
560 ([M+CH3CN+NH4]+, 100%), HRMS (ES+) exact mass calculated
for [M+Na]+ (C27H39N3O6Na+) requires m/z 524.2731, found m/z
524.2735; [a]D25 = +171.9 (c 1.0, CHCl3).
4.1.4. (4S,40S,400S)-3,30,300-Benzene-1,3,5-triyltris{4-[(2S)-butan-
2-yl]-1,3-oxazolidin-2-one} 4d
Prepared according to general procedure A, on a 1.4 mmol scale
of 1,3,5-tribromobenzene 6a. Reﬂuxed for 20 h (complete conver-
sion). Puriﬁed by chromatography on silica gel eluting with PE/
EtOAc 3:2? 2:3. The recovered solid was further puriﬁed by
recrystallisation from PE/EtOAc 2:1 to give 4d (0.420 g, 60%) as a
colourless crystalline solid. Mp 139–143 C; IR 1748 (C@O), 1603
(C@C), 1472 (C@C), 1400 (CH3); 1H NMR (CDCl3, 400 MHz) dH
0.87 (d, 9H, J 7.0 Hz, 3  CH3CH), 0.97 (t, 9H, J 7.5 Hz,
3  CH3CH2), 1.16–1.29 (m, 3H, 3  CH3CHAHB), 1.29–1.40 (m,
3H, 3  CH3CHAHB), 1.91–2.03 (m, 3H, 3  CH3CH), 4.25 (dd, 3H, J
9.0 Hz, 4.0 Hz, 3  NCHCHAHB), 4.41 (t, 3H, J 9.0 Hz,
3  NCHCHAHB), 4.57 (dt, 3H, J 9.0 Hz, 4.0 Hz, 3  NCHCH2), 7.63
(s, 3H, 3  H-Ar); 13C NMR (CDCl3, 100 MHz) dC 11.8 (CH3CH),
11.9 (CH3CH2), 25.3 (CH3CH2), 34.3 (CH3CH), 59.0 (NCH), 62.5
(NCHCH2), 109.4 (CH-Ar), 138.3 (Cquat-Ar), 155.7 (C@O); m/z (ES+)
519 ([M+NH4]+, 95%) 560 ([M+CH3CN+NH4]+, 100%), HRMS (ES+)
exact mass calculated for [M+Na]+ (C27H39N3O6Na+) requires m/z
524.2731 found m/z 524.2737; [a]D25 = +121.1 (c 1.0, CHCl3).
4.2. General procedure B for the preparation of C-2 symmetrical
N-aryloxazolidinones 4e–g
1,3-Dibromo-5-tert-butylbenzene 6b (1 equiv), potassium car-
bonate (3 equiv), copper(I) iodide (1 equiv) and an oxazolidinone
256 P. Jakubec et al. / Tetrahedron: Asymmetry 26 (2015) 251–2615 (3 equiv) were placed in a dry ﬂask, and 2 sequences vacuum/ni-
trogen were applied. Under nitrogen, dry toluene was added (2 mL
per mmol), and the suspension was stirred vigorously while N,N0-
dimethylethylenediamine was added in one portion (1 equiv).
The resulting dark suspension was reﬂuxed for 24 h (turned blue
after few minutes heating). The mixture was then allowed to cool
to room temperature under nitrogen and puriﬁed by chro-
matography on silica gel (the large amount of solid can be ﬁltered
on Celite prior to puriﬁcation, washing with ethyl acetate
thoroughly).
4.2.1. (4S,40S)-3,30-(5-tert-Butyl-1,3-phenylene)bis(4-isopropyl-
1,3-oxazolidin-2-one) 4e
Prepared according to general procedure B, on a 2.00 mmol
scale of 1,3-dibromo-5-tert-butylbenzene 6b. Reﬂuxed for 24 h.
Puriﬁed by chromatography on silica gel eluting with PE/Et2O
1:2? Et2O to afford 4e (0.528 g, 68%) as a colourless solid. Mp
61–63 C; IR 1746 (C@O), 1601 (C@C), 1457 (C@C), 1393 (CH3);
1H NMR (CDCl3, 400 MHz) dH 0.87 (d, 6H, J 7.0 Hz,
2  CH3CHCH3), 0.92 (d, 6H, J 7.0 Hz, 2  CH3CHCH3), 1.33 (s, 9H,
(CH3)3C), 2.14 (sept. d, 2H, J 7.0 Hz, 3.5 Hz, 2  CH3CHCH3), 4.21–
4.29 (m, 2H, 2  NCHCH2), 4.38–4.46 (m, 4H, 2  NCHCH2), 7.35
(d, 2H, J 2.0 Hz, H-Ar), 7.37–7.41 (m, 1H, H-Ar); 13C NMR (CDCl3,
100 MHz) dC 14.4 (CH3CHCH3), 17.7 (CH3CHCH3), 27.8
(CH3CHCH3), 31.2 ((CH3)3C), 35.1 ((CH3)3C)), 60.7 (NCHCH2), 62.5
(NCHCH2), 113.1 (CH-Ar), 116.4 (CH-Ar), 137.2 (Cquat-Ar), 153.3
(C@O), 155.9 (Cquat-Ar); m/z (ES+) 411 ([M+Na]+, 40%), 799
([2M+Na]+), 100%, HRMS (ES+) exact mass calculated for [M+Na]+
(C22H32N2O4Na+) requires m/z 411.2254, found m/z 411.2252;
[a]D25 = +71.7 (c 1.0, CHCl3).
4.2.2. (4S,40S)-3,30-(5-tert-Butyl-1,3-phenylene)bis(4-isobutyl-
1,3-oxazolidin-2-one) 4f
Prepared according to the general procedure, on a 1.63 mmol
scale of 1,3-dibromo-5-tert-butylbenzene 6b. Puriﬁed by chro-
matography on silica gel eluting with PE/EtOAc 7:3? 1:1 to afford
4f (0.633 g, 93%) as a colourless crystalline solid. Mp 138–141 C;
IR 1754 (C@O), 1603 (C@C), 1471 (C@C), 1398 (CH3); 1H NMR
(CDCl3, 500 MHz) dH 0.94 (d, 6H, J 6.5 Hz, 2  CH3CHCH3), 0.98
(d, 6H, J 6.5 Hz, 2  CH3CHCH3), 1.33 (s, 9H, (CH3)3C), 1.51 (ddd,
2H, J 13.0 Hz, 10.0 Hz, 4.5 Hz, 2  CHCHAHBCH), 1.56–1.68 (m,
2H, 2  CH3CHCH3), 1.73 (ddd, 2H, J 13.0 Hz, 10.0 Hz, 3.0 Hz,
2  CHCHAHBCH), 4.13 (dd, 2H, J 8.0 Hz, 5.0 Hz, 2  NCHCHAHBO),
4.45 (dddd, 2H, J 10.0 Hz, 8.0 Hz, 5.0 Hz, 3.0 Hz, 2  NCHCHAHBO),
4.55 (t, 2H, J 8.0 Hz, 2  NCHCHAHBO), 7.25 (d, 2H, J 2.0 Hz, H-Ar),
7.54 (t, 1H, J 2.0 Hz, H-Ar); 13C NMR (CDCl3, 125 MHz) dC 21.7
(CH3CHCH3), 23.6 (CH3CHCH3), 24.8 (CH3CHCH3), 31.2 ((CH3)3C)),
35.1 ((CH3)3C)), 41.1 (CHCH2CH), 55.0 (NCHCH2O), 67.6
(NCHCH2O), 111.9 (CH-Ar), 114.8 (CH-Ar), 137.3 (Cquat-Ar), 153.3,
155.5 (Cquat-Ar, C@O); m/z (ES+) 439 ([M+Na]+, 40%), 855
([2M+Na]+, 100%, HRMS (ES+) exact mass calculated for [M+Na]+
(C24H36N2O4Na+) requires m/z 439.2567, found m/z 439.2566;
[a]D25 = +108.9 (c 1.0, CHCl3).
4.2.3. (4S,40S)-3,30-(5-tert-Butyl-1,3-phenylene)bis{4-[(2S)-butan-2-
yl]-1,3-oxazolidin-2-one} 4g
Prepared according to general procedure B, on a 1.47 mmol
scale of 1,3-dibromo-5-tert-butylbenzene 6b. Puriﬁed by chro-
matography on silica gel eluting with PE/EtOAc 7:3? 1:1 to give
a solid that was crystallised from EtOAc/Et2O/PE (1:2:4, 7 mL),
affording 4g (0.525 g, 86%) as a colourless crystalline solid. Mp
123–125 C; IR 1748 (C@O), 1601 (C@C), 1458 (C@C), 1399
(CH3); 1H NMR (CDCl3, 500 MHz) dH 0.87 (d, 6H, J 6.5 Hz,
2  CH3CH), 0.95 (t, 6H, J 7.5 Hz, CH3CH2), 1.17–1.37 (m, 13H,
(CH3)3C, 2  CH3CH2), 1.85–1.95 (m, 2H, 2  CH3CH), 4.24 (dd,
2H, J 9.0 Hz, 4.5 Hz, 2  NCHCHAHB), 4.41 (t, 2H, J 9.0 Hz,2  NCHCHAHB), 4.51–4.57 (m, 2H, 2  NCHCHAHB), 7.34 (d, 2H, J
2.0 Hz, H-Ar), 7.44 (t, 1H, J 2.0 Hz, H-Ar); 13C NMR (CDCl3,
125 MHz) dC 11.7 (CH3CH), 11.9 (CH3CH2), 25.3 (CH3CH2), 31.2
((CH3)3C)), 34.3 (CH3CH), 35.1 ((CH3)3C), 59.2 (NCHCH2), 62.4
(NCHCH2), 112.6 (CH-Ar), 115.9 (CH-Ar), 137.1 (Cquat-Ar), 153.3
(C@O), 155.9 (Cquat-Ar); m/z (ES+) 439 ([M+Na]+, 40%), 855
([2M+Na]+, 100%, HRMS (ES+) exact mass calculated for [M+Na]+
(C24H36N2O4Na+) requires m/z 439.2567, found m/z 439.2569;
[a]D25 = +76.2 (c 1.0, CHCl3).
4.3. General procedure C for the preparation of sulfonic acids
2a–g
In a dry ﬂask under nitrogen, the substituted N-aryl oxazolidi-
none 4 (1 equiv) was dissolved in dry chloroform (30–50 mL per
mmol). The solution was stirred vigorously at room temperature
while chlorosulfonic acid (10 equiv) was added dropwise. The
cloudy solution was then heated at reﬂux, with a reverse Dean–
Stark apparatus (heavy solvent goes back in the ﬂask) for 24–
48 h. The resulting brown biphasic mixture was allowed to cool
down to room temperature and poured onto ice (50 mL per mmol),
washing the ﬂask twice with dichloromethane (5 mL per mmol
each time) and three times with DI water (10 mL per mmol each
time). The aqueous phase was collected and the organic layer
was extracted with DI water (5  20 mL per mmol). Aqueous layers
were combined and concentrated under reduced pressure to give a
brown oily residue which was puriﬁed by column chromatography
on silica gel and/or crystallisation.
The acids puriﬁed by column chromatography were placed into
1 M HCl (1 mL per 0.100 g of acid) and stirred with CH2Cl2 (1 mL
per 0.100 g of acid). The organic phase was separated and the aque-
ous phase was extracted with CHCl3/isopropanol 4:1 (2  1 mL per
0.100 g of acid). The combined organics were concentrated in
vacuo and dried to give free acid 2.
4.3.1. 2,4,6-Tris[(4S)-4-propyl-2-oxo-1,3-oxazolidin-3-yl]benze-
nesulfonic acid 2a
Prepared according to general procedure C on a 2.17 mmol of
4a. Reﬂuxed for 36 h. Puriﬁed by chromatography on silica gel elut-
ing with CH2Cl2/MeOH 9:1 to give 1.15 g of a light brown solid that
was crystallised from hot water (30 mL) to afford 2a (0.540 g, 47%)
as colourless crystals. Mp (water) 231–235 C (dec); IR 3430 (OH),
2962 (C–H), 1745 (C@O), 1200 (SO3), 1064 (SO3); 1H NMR (DMSO-
d6, 500 MHz) dH 0.86–0.91 (m, 9H, CH2CH3), 1.16–1.41 (m, 6H,
3  CH2CH3), 1.45–1.74 (m, 6H, 3  CH2CH2CH3), 4.04 (dd, 2H, J
8.0 Hz, 4.5 Hz, NCHCHAHB), 4.19 (dd, 1H, J 8.5 Hz, 4.5 Hz,
NCHCHAHB), 4.47 (t, 2H, J 8.0 Hz, NCHCHAHB), 4.56 (t, 1H, J
8.5 Hz, NCHCHAHB), 4.65–4.75 (m, 3H, NCH), 7.35 (s, 2H, H-Ar);
13C NMR (DMSO-d6, 500 MHz, 373 K) dC 13.0 (CH2CH3), 13.2
(CH2CH3), 16.2 (CH2CH3), 16.7 (CH2CH3), 32.9 (CH3CH2CH2), 34.2
(CH3CH2CH2), 54.3 (NCH), 57.4 (NCH), 66.3 (NCHCH2O), 67.2
(NCHCH2O), 123.7 (CH-Ar), 135.3 (NCquat-Ar), 136.4 (NCquat-Ar),
141.0 (HO3SCquat-Ar), 154.2 (C@O), 155.6 (C@O); m/z (ES) 538
([MH], 100%), HRMS (ES) exact mass calculated for [MH]
(C24H32N3O9S) requires m/z 538.1865, found m/z 538.1854;
[a]D25 = +26.2 (c 1.0, MeOH).
4.3.2. 2,4,6-Tris[(4S)-4-isopropyl-2-oxo-1,3-oxazolidin-3-yl]ben-
zenesulfonic acid 2b
Prepared according to general procedure C on a 1.85 mmol scale
of 4b. Reﬂuxed for 48 h. Puriﬁed by recrystallisation from acetoni-
trile to afford 2b (0.470 g, 47%) as colourless crystals suitable for sin-
gle crystal X-ray diffraction studies. Mp (acetonitrile) 130–133 C
(dec); IR 3400 (OH), 2965 (C–H), 1752 (C@O), 1395 (CH3), 1202
(SO3), 1056 (SO3); 1H NMR (DMSO-d6, 500 MHz) dH 0.76 (d, 3H, J
6.9 Hz, CH3CHCH3), 0.80 (d, 6H, J 6.9 Hz, 2  CH3CHCH3), 0.89 (d,
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1.83 (m, 2H, 2  CH3CHCH3), 1.98 - 2.06 (m, 1H, CH3CHCH3), 2.07 (s,
1H, CH3CN, ratio 2b:CH3CN 1:1), 4.18 (dd, J 8.4, 3.3 Hz, 2H,
2  NCHCHAHBO), 4.26–4.37 (m, 3H, 2  NCHCHAHBO,
NCHCHAHBO), 4.39–4.47 (m, 3H NCHCHAHBO, 2  NCHCHAHBO),
4.73 (dt, 1H, J 8.5, 3.5 Hz, NCHCHAHBO), 7.42 (s, 2H, H-Ar); 13C
NMR (DMSO-d6, 125 MHz) dC 1.2 (CH3CN), 14.2 (CH3CHCH3), 14.7
(CH3CHCH3), 17.1 (CH3CHCH3), 17.7 (CH3CHCH3), 27.3
(CH3CHCH3), 28.3 (CH3CHCH3), 58.6 (NCHCH2), 62.50, 62.53
(NCHCH2, NCHCH2O), 63.4 (NCHCH2O), 118.1 (CH3CN), 123.7 (CH-
Ar), 135.7 (Cquat-Ar), 137.0 (Cquat-Ar), 140.3 (Cquat-Ar), 154.9 (C@O),
156.6 (C@O); m/z (ES) 538 ([MH], 100%), HRMS (ES) exact
mass calculated for [MH] (C24H32N3O9S) requires m/z
538.1865, foundm/z 538.1871; [a]D25 = +42.1 (c 1.0, MeOH).
Single crystal X-ray diffraction data were collected at 150 K23
with a Nonius Kappa-CCD diffractometer and processed with
Denzo-SMN/SCALEPACK24 as per the SI (CIF). The structure was
solved with SuperFlip25 and reﬁned with CRYSTALS.26 The struc-
ture is highly disordered with one isopropyl-oxo-oxazolidin mod-
elled in two possible orientations. The compound is reported as
the sulfonate hydroxonium salt based on the S–O bond distances
(which are statistically indistinguishable) and the hydrogen bond-
ing in the solvent/water sphere. Careful examination of the differ-
ence Fourier map in the solvent region, although suggestive of
further disorder in the solvent space, supports this conclusion.
Full crystallographic data (in CIF format) are available as ESI and
has been deposited with the Cambridge Crystallographic Data
Centre (reference code 1027606).
4.3.3. 2,4,6-Tris[(4S)-4-isobutyl-2-oxo-1,3-oxazolidin-3-yl]benz-
enesulfonic acid 2c
Prepared according to general procedure C on a 1.26 mmol of
4c. Reﬂuxed for 48 h. Puriﬁed by chromatography on silica gel elut-
ing with dichloromethane/methanol 9:1 to give 2c (0.640 g, 88%)
as a light yellow amorphous solid. Acid 2c exists in DMSO-d6 as a
mixture of rotamers (according to 1H and 13C NMR at room tem-
perature). This observation was conﬁrmed by variable tempera-
tures (VT) NMR in DMSO-d6 at 100 C. Mp 242–245 C (dec); IR
3468 (OH), 2958 (C–H), 1751 (C@O), 1201 (SO3), 1087 (SO3), 758
(ArCH OOP); 1H NMR (DMSO-d6, 500 MHz, 298 K) dH Major rotamer
0.75 (d, 6H, J 6.6 Hz, 2  CH3CHCH3), 0.84 (d, 6H, J 6.6 Hz,
2  CH3CHCH3), 0.87 (d, 3H, J 6.6 Hz, CH3CHCH3), 0.94 (d, 3H, J
6.6 Hz, CH3CHCH3), 1.35–1.60 (m, 8H, 2  CHCH2CH,
2  CH3CHCH3, CHCH2CH), 1.61–1.69 (m, 1H, CH3CHCH3), 4.07
(dd, 2H, J 8.0 Hz, 5.0 Hz, 2  NCHCHAHBO), 4.21 (dd, 1H, J 8.5 Hz,
4.5 Hz, NCHCHAHBO), 4.43–4.53 (m, 2H, 2  NCHCHAHB), 4.58 (t,
1H, J 8.0 Hz, NCHCHAHBO), 4.65 (app. tt, 2H, J 9.0 Hz, 4.5 Hz,
2  NCH), 4.66–4.76 (m, 1H, NCH), 7.31 (s, 2H, H-Ar); 13C NMR
(DMSO-d6, 125 MHz, 298 K) dC 21.7 (CH3CHCH3), 21.9
(CH3CHCH3), 23.48 (CH3CHCH3), 23.54 (CH3CHCH3), 24.0
(CH3CHCH3), 24.1 (CH3CHCH3), 40.3 (CHCH2CH), 42.0 (CHCH2CH),
53.4 (NCH), 56.7 (NCH), 67.1 (NCHCH2O), 67.2 (NCHCH2O), 124.6
(CH-Ar), 135.5 (Cquat-Ar), 136.9 (Cquat-Ar), 140.6 (Cquat-Ar), 154.7
(C@O), 156.3 (C@O); 1H NMR (DMSO-d6, 500 MHz, 298 K) Minor
rotamer (observable) 0.65 (‘t’, 6H, J 6.0 Hz, 2  CH3CHCH3), 0.74
(d, 3H, J 6.5 Hz, CH3CHCH3), 1.04–1.10 (m, 1H, CH3CHCH3), 1.73–
1.83 (m, 1H, CHCHAHBCH), 3.80–3.87 (m, 1H, NCHCHAHBO), 3.98–
4.03 (m, 1H, NCH), 5.00–5.09 (m, 1H, NCH), 7.26 (br d, 1H, J
1.9 Hz, H-Ar), 7.52 (s, 1H, J 2.2 Hz, H-Ar); 13C NMR (DMSO-d6,
125 MHz, 298 K) Minor rotamers (observable) 21.95, 22.06, 22.9,
23.2, 23.4 23.9, 24.2 (CH3CHCH3), 40.4, 41.9 (CHCH2CH), 54.0,
55.6, 58.3, 67.3, 68.8, 68.9 (NCHCH2O), 123.0, 125.1, 136.0, 136.4,
137.4, 142.0, 154.7, 156.1, 156.2 (CH-Ar, Cquat-Ar, C@O).
4.3.3.1. VT NMR. 1H NMR (DMSO-d6, 500 MHz, 373 K) dH 0.79
(d, 6H, J 6.0 Hz, 2  CH3CHCH3), 0.85 (d, 6H, J 5.5 Hz,2  CH3CHCH3), 0.91 (d, 3H, J 6.5 Hz, CH3CHCH3), 0.96 (d, 3H,
CH3CHCH3, J 6.5 Hz), 1.40–1.62 (m, 8H, 2  CHCH2CH,
2  CH3CHCH3, CHCH2CH), 1.63–1.74 (m, 1H, CH3CHCH3), 4.02
(m, 2H, 2  NCHCHAHBO), 4.19 (dd, 1H, J 8.5 Hz, 4.5 Hz,
NCHCHAHBO), 4.51 (t, 2H, J 8.0 Hz, 2  NCHCHAHBO), 4.60 (t, 1H, J
8.0 Hz, NCHCHAHBO), 4.66 (ddd, 1H, J 13.0 Hz, 8.5 Hz, 4.5 Hz,
NCH), 4.76 (br, 2H, 2  NCH), 7.31 (s, 2H, H-Ar); 13C NMR
(DMSO-d6, 125 MHz, 373 K) dC 22.3 (CH3CHCH3), 22.5
(CH3CHCH3), 23.5 (br, CH3CHCH3), 23.7 (CH3CHCH3), 24.5
(CH3CHCH3), 24.7 (CH3CHCH3), 40.5 (CHCH2CH), 42.6 (br,
CHCH2CH), 54.4 (NCH), 67.8 (CH2O), 68.9 (br, CH2O), 125.2 (br,
CH-Ar), 136.4 (Cquat-Ar), 155.1 (C@O), 156.7 (C@O) (the other car-
bons were not detected at 373 K); m/z (ES) 580 ([MH],
100%), HRMS (ES) exact mass calculated for [MH]
(C27H38N3O9S) requires m/z 580.2334, found m/z 580.2323;
[a]D25 = +30.7 (c 1.0, MeOH).
4.3.4. (2,4,6-Tris{(4S)-4-[(2S)-butan-2-yl]-2-oxo-1,3-oxazolidin-
3-yl}benzenesulfonic acid 2d
Prepared according to general procedure C on a 0.80 mmol scale
of 4d. Reﬂuxed for 24 h. Puriﬁed by chromatography on silica gel
eluting with CH2Cl2/MeOH 95:5? 93:7 to give 0.450 g of a pale
brown amorphous solid that was crystallised from CH2Cl2 to afford
2d (250 mg, 54%) as light tan crystals. Mp 166–168 C (dec); IR
3435 (OH), 2965 (C–H), 1749 (C@O), 1200 (SO3), 1053 (SO3); 1H
NMR (DMSO-d6, 500 MHz) dH 0.75 (d, 3H, J 6.5 Hz, CHCH3), 0.82
(t, 6H, J 7.5 Hz, 2  CH2CH3), 0.90 (t, 3H, J 7.5 Hz, CH2CH3), 0.97
(d, 6H, J 6.5 Hz, CHCH3), 1.06–1.26 (m, 5H, 2  CH2CH3,
CHAHBCH3), 1.27–1.39 (m, 1H, CHAHBCH3), 1.47–1.58 (m, 2H,
2  CHCH3), 1.72–1.81 (m, 1H, CHCH3), 4.18 (dd, 2H, J 8.5 Hz,
3.0 Hz, 2  NCHCHAHBO), 4.32 (‘t’, 3H, J 8.5 Hz, 2  NCHCHAHBO,
NCHCHAHBO), 4.42 (t, 1H, J 8.5 Hz, NCHCHAHBO), 4.52 (dt, 2H, J
8.5 Hz, 3.0 Hz, 2  NCH), 4.82–4.87 (m, 1H, NCH), 7.39 (s, 2H, H-
Ar); 13C NMR (DMSO-d6, 125 MHz) dC 11.1 (CHCH3), 11.73 , 11.78
(CH3CH2, CHCH3), 24.3 (CH2CH3), 24.8 (CH2CH3), 33.9 (CHCH3),
35.2 (CHCH3), 57.5 (NCH), 62.0 (NCH), 62.4 (NCHCH2O), 63.6
(NCHCH2O), 123.5 (CH-Ar), 135.7 (NCquat-Ar), 136.9 (NCquat-Ar),
140.4 (HO3SCquat-Ar), 155.0 (C@O), 156.7 (C@O); m/z (ES) 580
([MH], 100%), HRMS (ES) exact mass calculated for [MH]
(C27H38N3O9S) requires m/z 580.2334 found m/z 580.2341;
[a]D25 = +38.4 (c 1.0, MeOH).
4.3.5. 4-tert-Butyl-2,6-bis[(4S)-4-isopropyl-2-oxo-1,3-oxazo-
lidin-3-yl]benzenesulfonic acid 2e
Prepared according to general procedure C on a 1.0 mmol scale
of 4e. Reﬂuxed for 48 h. Puriﬁed by chromatography on silica gel
eluting with CH2Cl2/MeOH 9:1 to afford 2e (0.440 g, 94%) as an
off-white foamy solid. Mp 260–262 C (dec); IR 3437 (OH), 2965
(C–H), 1733 (C@O), 1229 (SO3), 1079 (SO3), 1035 (SO3); 1H NMR
(DMSO-d6, 500 MHz) dH 0.81 (d, 6H, J 7.0 Hz, 2  CH3CHCH3),
0.99 (d, 6H, J 7.0 Hz, 2  CH3CHCH3), 1.28 (s, 9H, C(CH3)3), 1.73–
1.79 (m, 2H, 2  CH3CHCH3), 4.19 (dd, 2H, J 8.5 Hz, 3.0 Hz,
2  NCHCHAHBO), 4.31 (t, 2H, J 8.5 Hz, 2  NCHCHAHBO), 4.41 (dt,
2H, J 8.5 Hz, 3.0 Hz, 2  NCH, 7.10 (s, 2H, H-Ar); 13C NMR
(DMSO-d6, 125 MHz) dC 14.7 (CH3CHCH3), 17.7 (CH3CHCH3), 28.4
(CH3CHCH3), 30.6 (C(CH3)3), 34.0 (C(CH3)3), 62.4 (NCH), 63.4
(NCHCH2O), 129.1 (CH-Ar), 134.9 (NCquat-Ar), 142.0 (HO3SCquat-Ar),
151.4 (Cquat-Ar), 156.8 (C@O); m/z (ES) 467 ([MH], 100%),
HRMS (ES) exact mass calculated for [MH] (C22H31N2O7S)
requires m/z 467.1857, found m/z 467.1860; [a]D25 = +56.7 (c 1.0,
MeOH).
4.3.6. 4-tert-Butyl-2,6-bis[(4S)-4-isobutyl-2-oxo-1,3-oxazolidin-
3-yl]benzenesulfonic acid 2f
Prepared according to general procedure C on a 1.44 mmol of 4f.
Reﬂuxed for 24 h. Puriﬁed by chromatography on silica gel eluting
258 P. Jakubec et al. / Tetrahedron: Asymmetry 26 (2015) 251–261with CH2Cl2/MeOH 95:5? 93:7 to give 0.633 g of a light tan foamy
solid that was recrystallised from CH2Cl2/Et2O (1:2, 3 mL) to afford
2f (0.350 g, 49%). Acid 2f exists in DMSO-d6 as a mixture of rota-
mers (according to 1H NMR at room temperature). This observation
was conﬁrmed by variable temperatures (VT) NMR in DMSO-d6 at
100 C. Mp 223–226 C (dec); IR 3437 (OH), 2958 (C–H), 1740
(C@O), 1227 (SO3), 1077 (SO3), 1029 (SO3), 755 (ArCH OOP); 1H
NMR (DMSO-d6, 500 MHz, 298 K) Major rotamer dH 0.74 (d, 6H, J
6.3 Hz, CH3CHCH3), 0.82 (d, 6H, J 6.3 Hz, CH3CHCH3), 1.28 (s, 9H,
C(CH3)3), 1.32–1.52 (m, 6H, 2  NCHCH2CH), 4.02 (dd, 2H, J
7.9 Hz, 5.0 Hz, 2  NCHCHAHBO), 4.43–4.46 (m, 2H,
2  NCHCHAHBO), 4.60 (ddd, 2H, J 13.1 Hz, 8.8 Hz, 4.6 Hz,
2  NCH), 7.12 (s, 2H, H-Ar); 13C NMR (DMSO-d6, 125 MHz,
298 K) dC 22.0 (CH3CHCH3), 23.3 (CH3CHCH3), 24.1 (CH3CHCH3),
30.7 ((CH3)3C), 34.0 ((CH3)3C), 41.9 (CHCH2CH), 56.4 (NCH), 68.1
(NCHCH2O), 130.0 (CH-Ar), 134.6 (Cquat-Ar), 141.9 (Cquat-Ar),
151.2 (Cquat-Ar), 156.3 (C@O); 1H NMR (DMSO-d6, 500 MHz,
298 K) Minor rotamers (observable) 0.63 (‘t’, 6H, J 6.0 Hz,
2  CH3CHCH3), 0.67–0.70 (m, 3H, CH3CHCH3), 0.98–1.06 (m, 1H,
CH3CHCH3), 1.26 (s, 9H, C(CH3)3), 1.75–1.80 (m, 1H, CHCHAHBCH),
3.81 (dd, 1H, J 10.1 Hz, 8.2 Hz, CHCHAHBO), 3.94 (dd, 1H, J 7.7 Hz,
6.1 Hz, CHCHAHBO), 4.31–4.37 (m, 1H, NCH), 4.90–4.96 (m, 1H,
NCH), 7.38 (d, 1H, J 1.6 Hz, H-Ar); 13C NMR (DMSO-d6, 125 MHz,
298 K) Minor rotamers dC 21.7, 22.3, 22.8, 22.9 (CH3CHCH3), 30.7
((CH3)3C), 34.2 ((CH3)3C), 40.1, 42.9 (CHCH2CH), 55.4, 57.9, 62.0,
68.7, 68.8 (NCHCH2O), 126.7, 129.9, 135.0, 135.5, 142.6, 152.0,
156.3, 156.3 (CH-Ar, Cquat-Ar, C@O).
4.3.6.1. VT NMR. 1H NMR (DMSO-d6, 500 MHz, 373 K) dH
0.74–0.80 (br m, 6H, CH3CHCH3), 0.80–0.86 (br m, 6H,
CH3CHCH3), 1.31 (s, 9H, ((CH3)3C)), 1.36–1.60 (br m, 6H,
2  NCHCH2CH), 3.95–4.02 (br m, 2H, 2  NCHCHAHBO), 4.49 (t,
2H, J 8.0 Hz, 2  NCHCHAHBO), 4.60–4.90 (br m, 2H, 2  NCH),
7.14 (br s, 2H, H-Ar); m/z (ES) 495 ([MH], 100%), HRMS
(ES) exact mass calculated for [MH] (C24H35N2O7S) requires
m/z 495.2170, found m/z 495.2173; [a]D25 = +44.4 (c 1.0, MeOH).
4.3.7. 2,6-Bis{(4S)-4-[(2S)-butan-2-yl]-2-oxo-1,3-oxazolidin-3-
yl}-4-tert-butylbenzenesulfonic acid 2g
Prepared according to general procedure C on a 1.22 mmol scale
of 4g. Reﬂuxed for 24 h. Puriﬁed by chromatography on silica gel
eluting with CH2Cl2/MeOH 95:5? 93:7 to give 2g (0.556 g, 92%)
as a colourless amorphous solid. Mp 233–236 C (dec); IR 3436
(OH), 2965 (C–H), 1739 (C@O), 1227 (SO3), 1078 (SO3), 1033
(SO3); 1H NMR (DMSO-d6, 500 MHz) dH 0.82 (t, 6H, J 7.5 Hz,
2  CH2CH3), 0.99 (d, 6H, 2  CHCH3, J 7.0 Hz), 1.07–1.21 (m, 4H,
2  CH2CH3), 1.28 (s, 9H, C(CH3)3), 1.42–1.56 (m, 2H, 2  CHCH3),
4.16 (dd, 2H, J 8.5 Hz, 3.0 Hz, 2  NCHCHAHBO), 4.31 (t, 2H, J
8.5 Hz, 2  NCHCHAHBO), 4.51 (dt, 2H, J 8.5 Hz, 3.0 Hz,
2  NCHCHAHBO), 7.09 (s, 2H, H-Ar); 13C NMR (DMSO-d6,
125 MHz) dC 11.7 (CH2CH3, CHCH3), 24.8 (CH2CH3), 30.5
(C(CH3)3), 34.0 (C(CH3)3), 35.0 (CHCH3), 61.7 (NCHCH2O), 63.4
(NCHCH2O), 129.0 (CH-Ar), 134.8 (Cquat-Ar), 142.0 (HO3SCquat-Ar),
151.3 (Cquat-Ar), 156.8 (C@O); m/z (ES) 495 ([MH], 100%),
HRMS (ES) exact mass calculated for [MH] (C24H35N2O7S)
requires m/z 495.2170, found m/z 495.2176; [a]D25 = +74.2 (c 1.0,
MeOH).
4.4. [2-(Ethoxysulfonyl)phenyl]boronic acid 11
To a solution of ethyl benzenesulfonate 10 (15.60 mmol,
2.900 g) in THF (39 mL) was added dropwise n-BuLi (1.1 equiv,
17.10 mmol, 6.90 mL of 2.5 M solution in hexanes) at 78 C. The
resulting yellow solution was stirred for 5 h before being quenched
with B(OMe)3 (1.5 equiv, 23 mmol, 3.4 g, 4.0 mL) at 78 C. The
resulting mixture was warmed to rt over 1 h and 1 M HCl(40 mL) was added. The resulting mixture was stirred at rt for
12 h. The organic phase was separated and the water phase was
extracted with Et2O (3  30 mL). Dried combined organics
(Na2SO4) were concentrated in vacuo and the residue was recrys-
tallised (PE/Et2O 5:1) to afford 11 (3.310 g, 92%) as a mixture of
the acid with the dehydrated form, which was used in the next
step. Further recrystallisation afforded pure 11. Mp 62–65 C
(PE–Et2O); IR 3456 (OH), 2988 (C–H), 1338, 1180 (SO3Et); 1H
NMR (CDCl3, 400 MHz) dH 1.33 (t, 3H, J 7.2 Hz, OCH2CH3), 4.15 (q,
2H, J 7.2 Hz, OCH2CH3), 4.88 (br s, 2H, B(OH)2), 7.61 (dt, 1H, J
7.7 Hz, 1.5 Hz, H-Ar), 7.69 (dt, 1H, J 7.5 Hz, 1.2 Hz, H-Ar), 8.04–
8.08 (m, 2H, H-Ar); 13C NMR (CDCl3, 100 MHz) dC 14.6
(OCH2CH3), 67.7 (OCH2CH3), 128.8 (CH-Ar), 130.3 (CH-Ar), 133.3
(CH-Ar), 136.8 (CH-Ar), 138.9 (Cquat-Ar); HRMS (FI+) exact mass
calculated for [M-H2O]+ (C8H9BO4S+) requires m/z 212.0309, found
m/z 211.9832.
4.5. Ethyl 2-[(3R,6S)-6-isopropyl-3-methylcyclohex-1-en-1-
yl]benzenesulfonate 12
A mixture of boronic acid 11 (10.50 mmol, 2.414 g), Cs2CO3
(10.50 mmol, 3.414 g) and triﬂate 8a (8.70 mmol, 2.500 g of tri-
ﬂate) in dimethoxyethane (30 mL) and water (5 mL) was degassed
and ﬁlled with nitrogen. Next, (Ph3P)4Pd (0.05 equiv, 0.44 mmol,
0.505 g) was added and the mixture was stirred at 70 C. After all
starting material had been consumed (TLC monitoring, 1 h) the
mixture was cooled to rt and concentrated in vacuo. Water
(35 mL) was added and the mixture was extracted with Et2O
(3  10 mL). Dried combined organics (Na2SO4) were concentrated
in vacuo and the residue was puriﬁed by column chromatography
(PE? PE/Et2O 98:2? PE/Et2O 95:5) to yield 12 (2.191 g, 78%) as a
colourless oil. IR 2958, 2932, 2869 (C–H), 1356, 1182 (SO3Et); 1H
NMR (CDCl3, 400 MHz) dH 0.70 (d, 3H, J 6.8 Hz, CH3CHCH3), 0.84
(d, 3H, J 6.8 Hz, CH3CHCH3), 1.01 (d, 3H, J 7.1 Hz, CH3CHCH2),
1.27–1.45 (m, 5H, OCH2CH3, CHAHBCHCHCH3, CHAHBCHCH3),
1.48–1.56 (m, 1H, CH3CHCH3), 1.77–1.86 (m, 2H,
CHAHBCHCHCH3, CHAHBCHCH3), 2.22–2.29 (m, 1H, CH3CHCH2),
2.97 (broad s, 1H, CH3CHCH), 3.99–4.12 (m, 2H, OCH2CH3), 5.48
(s, 1H, CH–CH@Cquat), 7.30 (dd, 1H, J 7.6 Hz, 1.3 Hz, H-Ar), 7.37
(td, 1H, J 7.7 Hz, 1.3 Hz, H-Ar), 7.53 (td, 1H, J 7.6 Hz, 1.2 Hz, H-
Ar), 7.98 (dd, 1H, J 8.1 Hz, 1.3 Hz, H-Ar); 13C NMR (CDCl3,
100 MHz) dC 14.7 (OCH2CH3), 16.2 (CH3CHCH3), 20.9 (CH3CHCH3),
21.4 (CHCHCH2), 21.6 (CH3CHCH2), 28.4 (CH3CHCH3), 30.5
(CH2CHCH3), 31.4 (CH2CHCH3), 43.0 (CH3CHCH), 66.6 (OCH2CH3),
126.7 (CH-Ar), 129.7 (CH-Ar), 132.5 (CH-Ar), 133.0 (CH-Ar), 134.0
(Cquat-Ar), 136.6 (CH–CH@Cquat), 141.1 (Cquat), 143.9 (Cquat);
HRMS (ES+) exact mass calculated for [M+Na]+ (C18H26NaO3S+)
requires m/z 345.1495, found m/z 345.1497; [a]D25 = +50.7 (c 4.02,
CHCl3).
4.6. {2-(Ethoxysulfonyl)-3-[(3R,6S)-6-isopropyl-3-methyl-
cyclohex-1-en-1-yl]phenyl}boronic acid 13
To a solution of benzenesulfonate 12 (3.100 mmol, 1.000 g) in
THF (13.2 mL) was added dropwise n-BuLi (1.1 equiv, 3.4 mmol,
1.4 mL of 2.5 M solution in hexanes) at 78 C. The resulting yel-
low-orange solution was stirred for 6.5 h at 78 C before being
quenched with B(OMe)3 (1.5 equiv, 4.70 mmol, 0.679 g, 0.792 mL)
at 78 C. The resulting mixture was warmed to rt over 1 h, after
which 1 M HCl (40 mL) was added and the mixture was stirred at
rt for 1 h. The organic phase was separated and the aqueous phase
was extracted with Et2O (3  30 mL). The combined organics were
washed (brine, 10 mL), dried (Na2SO4) and concentrated in vacuo
affording 13 (1.141 g, 100%) as a colourless oil. The crude product
containing a mixture of boronic acid and its dehydrated forms was
used in the next step without further puriﬁcation.
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with triﬂates 8a,b
A mixture of boronic acid 13 (1.5–2 equiv), Cs2CO3 (2 equiv) tri-
ﬂate 8 (1 equiv) in dimethoxyethane/water (5:1) was degassed and
ﬁlled with nitrogen. Next, (Ph3P)4Pd (0.05 equiv) was added and
the mixture was stirred at 70 C. After all starting material had
been consumed (TLC monitoring, typically 1–2 h) the mixture
was cooled to rt and concentrated in vacuo. Water (8.4 mL per
mmol of 8) was added and the mixture was extracted with Et2O
(3  8.4 mL per mmol of 8). Dried combined organics (Na2SO4)
were concentrated in vacuo and the residue was puriﬁed by col-
umn chromatography.4.7.1. Ethyl 2,6-bis[(3R,6S)-6-isopropyl-3-methylcyclohex-1-en-
1-yl]benzenesulfonate 7a
According to general procedure D (for 1.19 mmol, 0.435 g of 13
used 0.030 mmol, 0.034 g of (Ph3P)4Pd; 0.590 mmol, 0.170 g of tri-
ﬂate 8a; 1.19 mmol, 0.384 g of Cs2CO3; 2.0 ml of dimethoxyethane,
0.4 mL of water at 70 C for 1 h) 7a (0.205 g, 76%) was obtained as a
colourless oil after column chromatography (PE? PE/Et2O
98:2? PE/Et2O 95:5). IR 2957, 2931, 2869 (C–H), 1355, 1179
(SO3Et); 1H NMR (CDCl3, 400 MHz) dH 0.77 (d, 6H, J 6.8 Hz,
2  CH3CHCH3), 0.86 (d, 6H, J 6.8 Hz, 2  CH3CHCH3), 1.04 (d, 6H,
J 7.0 Hz, 2  CH3CHCH2), 1.30–1.50 (m, 7H, OCH2CH3,
2  CHAHBCHCHCH3, 2  CHAHBCHCH3), 1.58–1.65 (m, 2H,
2  CH3CHCH3), 1.79–1.84 (m, 4H, 2  CHAHBCHCHCH3,
2  CHAHBCHCH3), 2.19–2.30 (m, 2H, 2  CH3CHCH2), 2.96 (broad
s, 2H, 2  CH3CHCH), 4.05–4.17 (m, 2H, OCH2CH3), 5.48 (s, 2H,
2  CH–CH@Cquat), 7.15 (d, 2H, J 7.5 Hz, H-Ar), 7.35 (t, 1H, J
7.7 Hz, H-Ar); 13C NMR (CDCl3, 100 MHz) dC 15.2 (OCH2CH3), 16.9
(CH3CHCH3), 21.3, 21.4, 21.6 (CH3CHCH3, CH3CHCH2,
CH2CHCHCH3), 28.3 (CH3CHCH3), 30.3 (CH2CHCH3), 31.2
(CH2CHCH3), 43.2 (CHCHCH3), 65.6 (OCH2CH3), 130.7 (CH-Ar),
131.4 (CH-Ar), 134.2 (Cquat), 135.1 (CHCH@Cquat), 142.5 (Cquat),
144.6 (Cquat); HRMS (EI/FI) exact mass calculated for [M]+
(C28H42O3S+) requires m/z 458.2855, found m/z 458.3151;
[a]D25 = +78.6 (c 0.22, CHCl3).4.7.2. Ethyl 40-tert-butyl-3-[(3R,6S)-6-isopropyl-3-methylcyclo-
hex-1-en-1-yl]biphenyl-2-sulfonate 7b
According to general procedure D (for 0.75 mmol, 0.275 g of 13
used 0.025 mmol, 0.029 g of (Ph3P)4Pd; 0.50 mmol, 0.141 g of tri-
ﬂate 8b; 0.75 mmol, 0.244 g of Cs2CO3; 2.0 ml of dimethoxyethane,
0.4 mL of water at 70 C for 1 h) 7b (0.142 g, 83%) was obtained as a
colourless oil after column chromatography ((PE? PE/Et2O
98:2? PE/Et2O 95:5). IR 2958, 2933, 2869 (C–H), 1354, 1177
(SO3Et); 1H NMR (CDCl3, 500 MHz) d 0.68 (d, 3H, J 6.6 Hz,
CH3CHCH3), 0.92 (d, 3H, J 6.9 Hz, CH3CHCH3), 1.03 (t, 3H, J 6.9 Hz,
OCH2CH3), 1.06 (d, 3H, J 6.9 Hz, CH3CHCH2), 1.33–1.49 (m, 11H,
(CH3)3C, CHAHBCHCHCH3, CHAHBCHCH3), 1.60–1.67 (m, 1H,
CH3CHCH3), 1.85–1.89 (m, 2H, CHAHBCHCHCH3, CHAHBCHCH3),
2.24–2.35 (m, 1H, CH3CHCH2), 3.03–3.12 (m, 1H, CH3CHCH),
3.72–3.84 (m, 2H, OCH2CH3), 5.63 (s, 1H, CH–CH@Cquat), 7.25 (d,
1H, J 7.6 Hz, H-Ar), 7.29 (d, 1H, J 7.6 Hz, H-Ar), 7.37 (broad s, 2H,
H-Ar), 7.42–7.48 (m, 3H, H-Ar); 13C NMR (CDCl3, 125 MHz) d 14.5
(OCH2CH3), 16.4 (CH3CHCH3), 21.0 (CH3CHCH3), 21.7, 21.7
(CH3CHCH2, CH2CHCHCH3), 28.8 (CH3CHCH3), 30.3 (CH2CHCH3),
31.4, 31.5 ((CH3)3C, CH2CHCH3), 34.6 ((CH3)3C), 43.4 (CHCHCH3),
65.7 (OCH2CH3), 124.6 (CH-Ar), 128.6 (Cquat), 131.4 (CH-Ar),
131.4 (CH-Ar), 131.7 (CH-Ar), 133.7 (Cquat), 135.3 (CHCH@Cquat),
138.4 (Cquat), 142.9 (Cquat), 143.4 (Cquat), 145.2 (Cquat), 150.5
(Cquat); HRMS (ESI+) exact mass calculated for [M+Na]+
(C28H38NaO3S+) requires m/z 477.2434, found m/z 477.2438;
[a]D25 = +78.1 (c 1.12, CHCl3).4.8. General procedure E for the synthesis of sodium salts of
sulfonic acids 14
A mixture of ester 7 (0.100 g) in EtOH (10 mL) and 1 M NaOH
(10 mL) was stirred at reﬂux. After 14 h the mixture was cooled
to rt and concentrated in vacuo. Water (30 mL) was then added
and the suspension was stirred at rt for 10 min. The insoluble solid
was ﬁltered off, washed (water) and dried to yield the sodium salt
of sulfonic acid 14 as a colourless solid.
4.8.1. Sodium 2,6-bis[(3R,6S)-6-isopropyl-3-methylcyclohex-1-
en-1-yl]benzenesulfonate 14a
According to general procedure E (for 1.07 mmol, 0.490 g of the
ester 7a used 66 mL of 1 M solution of NaOH, 66 mL of EtOH) the
salt 14a (0.480 g, 99%) was obtained as a colourless solid. Mp
152–156 C; IR 2957, 2929, 2868 (C–H), 1366, 1191 (SO3); 1H
NMR (DMSO-d6, 500 MHz) dH 0.69 (d, 6H, J 6.8 Hz,
2  CH3CHCH3), 0.76 (d, 6H, J 6.8 Hz, 2  CH3CHCH3), 0.94 (d, 6H,
J 6.9 Hz, 2  CH3CHCH2), 1.27–1.35 (m, 4H, 2  CHAHBCHCHCH3,
2  CHAHBCHCH3), 1.57–1.71 (m, 6H, 2  CH3CHCH3,
2  CHAHBCHCHCH3, 2  CHAHBCHCH3), 2.06–2.17 (m, 2H,
2  CH3CHCH2), 3.15 (broad s, 2H, 2  CH3CHCH), 5.15 (s, 2H,
2  CH–CH@Cquat), 6.82 (d, 2H, J 7.3 Hz, H-Ar), 7.04 (t, 1H, J
7.6 Hz, H-Ar); 13C NMR (DMSO-d6, 125 MHz) dC 16.9 (CH3CHCH3),
21.1 (CH3CHCHCH2), 21.3 (CH3CHCH3), 21.9 (CH3CHCH2), 27.7
(CH3CHCH3), 29.9 (CH2CHCH3), 30.6 (CH2CHCH3), 42.1
(CHCHCH3), 125.8 (CH-Ar), 129.5 (CH-Ar), 130.4 (CHCH@Cquat),
141.6 (Cquat), 144.8 (Cquat), 145.1 (Cquat); HRMS (ESI+) exact mass
calculated for [MNa+] (C26H37O3S) requires m/z 429.2469,
found m/z 429.2477; [a]D25 = +51.3 (c 1.18, MeOH).
4.8.2. Sodium 40-tert-butyl-3-[(3R,6S)-6-isopropyl-3-methyl-
cyclohex-1-en-1-yl]biphenyl-2-sulfonate 14b
According to general procedure E (for 0.22 mmol, 0.102 g of 7b
used 11 mL of 1.0 M NaOH, 11 mL of EtOH) 14b (0.094 g, 91%) was
obtained as a colourless solid. Mp 288–290 C; IR (ﬁlm) 2957,
2931, 2868 (C–H), 1364, 1218 (SO3); 1H NMR (DMSO-d6,
500 MHz) dH 0.57 (d, 3H, J 6.9 Hz, CH3CHCH3), 0.79 (d, 3H, J
6.9 Hz, CH3CHCH3), 0.94 (d, 3H, J 6.9 Hz, CH3CHCH2), 1.24–1.31
(m, 11H, (CH3)3C, CHAHBCHCHCH3, CHAHBCHCH3), 1.53–1.63 (m,
1H, CH3CHCH3), 1.64–1.76 (m, 2H, CHAHBCHCHCH3,
CHAHBCHCH3), 2.12–2.23 (m, 1H, CH3CHCH2), 3.42–3.51 (m, 1H,
CH3CHCH), 5.26 (broad s, 1H, CH–CH@Cquat), 6.91 (d, 1H, J 7.6 Hz,
H-Ar), 6.99 (d, 1H, J 7.3 Hz, H-Ar), 7.17 (t, 1H, J 7.3 Hz, H-Ar), 7.25
(d, 2H, J 8.5 Hz, H-Ar), 7.35 (d, 2H, J 8.2 Hz, H-Ar); 13C NMR
(DMSO-d6, 125 MHz) dC 16.4 (CH3CHCH3), 21.0 (CH3CHCH3), 21.4
(CHCHCH2), 22.0 (CH3CHCH2), 28.3 (CH3CHCH3), 30.0
(CH2CHCH3), 30.9 (CH2CHCH3), 31.4 (C(CH3)3), 34.0 (C(CH3)3),
41.7 (CH3CHCH), 123.3 (CH-Ar), 127.1 (CH-Ar), 128.7 (CH-Ar),
129.9 (CH-Ar), 130.3, 130.4 (CH-Ar, CH–CH@Cquat), 141.0 (Cquat),
142.0 (Cquat), 142.7 (Cquat), 144.0 (Cquat), 146.6 (Cquat), 147.1
(Cquat); HRMS (ESI) exact mass calculated for [MNa+]
(C26H33O3S+) requires m/z 425.2156, found m/z 425.2164;
[a]D25 = +55.5 (c 0.55, MeOH).
4.9. General procedure F for the synthesis of sulfonic acids 2h,i
from their salt 14
A suspension of Na-salt 14 in 0.5 M HCl (10 mL per 0.100 g) was
extracted with Et2O (10 mL). The organic layer was concentrated
by a stream of nitrogen to afford acid 2.
4.9.1. 2,6-Bis[(3R,6S)-6-isopropyl-3-methylcyclohex-1-en-1-yl]-
benzenesulfonic acid 2h
According to general procedure F (for 0.070 mmol, 0.030 g of
14a used 3 mL of 0.5 M HCl and 3 mL of Et2O) 2h (0.025 g, 86%)
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(C–H), 1367, 1173 (SO3); 1H NMR (DMSO-d6, 500 MHz) dH 0.70
(d, 6H, J 6.6 Hz, 2  CH3CHCH3), 0.77 (d, 6H, J 6.9 Hz,
2  CH3CHCH3), 0.94 (d, 6H, J 6.9 Hz, 2  CH3CHCH2), 1.23–1.36
(m, 4H, 2  CHAHBCHCHCH3, 2  CHAHBCHCH3), 1.56–1.69 (m,
6H, 2  CH3CHCH3, 2  CHAHBCHCHCH3, 2  CHAHBCHCH3), 2.08–
2.18 (m, 2H, 2  CH3CHCH2), 3.00–3.13 (m, 2H, 2  CH3CHCH),
5.19 (broad s, 2H, 2  CH–CH@Cquat), 6.87 (d, 2H, J 7.6 Hz, H-Ar),
7.11 (t, 1H, J 7.6 Hz, H-Ar); 13C NMR (DMSO-d6, 125 MHz) dC 16.9
(CH3CHCH3), 21.1 (CH3CHCHCH2), 21.3 (CH3CHCH3), 21.8
(CH3CHCH2), 27.7 (CH3CHCH3), 29.9 (CH2CHCH3), 30.6
(CH2CHCH3), 42.4 (CHCHCH3), 126.6 (CH-Ar), 129.7 (CH-Ar),
131.2 (CHCH@Cquat), 141.8 (Cquat), 143.6 (Cquat), 144.1 (Cquat); MS
(ES) m/z (relative intensity) 429.64 (M-H+, 100%); [a]D25 = +52.9
(c 0.38, MeOH).
4.9.2. 4-tert-Butyl-3-[(3R,6S)-6-isopropyl-3-methylcyclohex-1-
en-1-yl]biphenyl-2-sulfonic acid 2i
According to general procedure F (for 0.20 mmol, 0.094 g of 14b
used 10 mL of 1.0 M HCl and 20 mL of Et2O) 2i (0.086 g, 97%) was
obtained as a white solid. Mp 78–84 C; 1H NMR (DMSO-d6,
500 MHz) dH 0.57 (d, 3H, J 6.6 Hz, CH3CHCH3), 0.79 (d, 3H, J
6.6 Hz, CH3CHCH3), 0.94 (d, 3H, J 6.9 Hz, CH3CHCH2), 1.23–1.33
(m, 11H, (CH3)3C, CHAHBCHCHCH3, CHAHBCHCH3), 1.53–1.61 (m,
1H, CH3CHCH3), 1.65–1.71 (m, 2H, CHAHBCHCHCH3,
CHAHBCHCH3), 2.14–2.22 (m, 1H, CH3CHCH2), 3.44 (broad s, 1H,
CH3CHCH), 5.27 (broad s, 1H, CH–CH@Cquat), 6.92 (d, 1H, J 7.3 Hz,
H-Ar), 7.00 (d, 1H, J 7.3 Hz, H-Ar), 7.19 (t, 1H, J 7.6 Hz, H-Ar), 7.25
(d, 2H, J 8.5 Hz, H-Ar), 7.34 (d, 2H, J 7.9 Hz, H-Ar); 13C NMR
(DMSO-d6, 125 MHz) dC 16.4 (CH3CHCH3), 21.0 (CH3CHCH3), 21.4
(CHCHCH2), 22.0 (CH3CHCH2), 28.3 (CH3CHCH3), 30.0
(CH2CHCH3), 31.0 (CH2CHCH3), 31.4 (C(CH3)3), 34.1 (C(CH3)3),
41.7 (CH3CHCH), 123.4 (CH-Ar), 127.3 (CH-Ar), 128.7 (CH-Ar),
130.0, 130.4, 130.6 (CH-Ar, CH-Ar, CH–CH@Cquat), 141.0 (Cquat-Ar),
141.9 (Cquat-Ar), 142.7 (Cquat-Ar), 143.6 (Cquat-Ar), 146.5 (Cquat-Ar),
147.2 (Cquat-Ar); MS (ES) m/z (relative intensity) 425.45 (M-H+,
100%); [a]D25 = +57.5 (c 0.16, MeOH).
4.10. General procedure G for the enantioselective synthesis of
isoxazolidines (R,R)-17 using catalyst 2a–g
Ethyl vinyl ether 16 (1.50 mmol, 0.108 g, 0.143 mL) was added
to a mixture of nitrone 15 (0.300 mmol, 0.0590 g) and 4 Å MS
(powder, 0.020 g) in CHCl3 (6.0 mL). The resulting mixture was
cooled to 35 C and catalyst 2 (0.0300 mmol) was added under
nitrogen. After 24 h NaHCO3 (saturated aqueous solution, 6 mL)
was added and the separated aqueous layer was extracted with
CH2Cl2 (6 mL). The combined organics were dried (Na2SO4) and
concentrated in vacuo. The crude mixture was puriﬁed by column
chromatography (PE/Et2O 98:2? 95:5) yielding a diastereomeric
mixture of isoxazolidines 17 as a colourless solid.27 The enan-
tiomeric excess was determined by HPLC using a chiral stationary
phase (Chiralcel IA column, 99:1 hexanes/i-PrOH, 1.0 mL/min,
220 nm, minor enantiomer tr = 6.2 min, major enantiomer tr =
8.1 min).28 All spectroscopic NMR characterisation data (1H and
13C NMR) are in good agreement with the published data.21
4.11. General procedure H for the enantioselective synthesis of
isoxazolidines (S,S)-17 using catalyst 2h,i
Ethyl vinyl ether 16 (1.50 mmol, 0.108 g, 0.143 mL) was added
to a mixture of nitrone 15 (0.300 mmol, 0.0590 g) and 4 Å MS
(powder, 0.020 g) in CH2Cl2 (6.0 mL). The resulting mixture was
cooled to 40 C, after which catalyst 2 (0.0300 mmol) was added
under nitrogen. After 24 h NaHCO3 (saturated aqueous solution,
6 mL) was added and the separated aqueous layer was extractedwith CH2Cl2 (6 mL). The combined organics were dried (Na2SO4)
and concentrated in vacuo. The crude mixture was puriﬁed by col-
umn chromatography (PE/Et2O 98:2? 95:5) yielding a diastere-
omeric mixture of isoxazolidines 17 as a colourless solid.27 The
enantiomeric excess was determined by HPLC using a chiral sta-
tionary phase (Chiralcel AI column, 99:1 hexanes/i-PrOH, 1.0 mL/
min, 220 nm, major enantiomer tr = 6.2 min, minor enantiomer
tr = 8.1 min).28 All spectroscopic NMR characterisation data (1H
and 13C NMR) are in good agreement with the published data.21Acknowledgements
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